Codexis Total Non Current Liabilities 2011-2026 | CDXS

Annual Total Non Current Liabilities Codexis

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	28.2 M	4.86 M	4.13 M	4.18 M	6.93 M	8.08 M	6.16 M	5.24 M	4.94 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
28.2 M	4.13 M	8.08 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Altimmune ALT	4.4 M	$ 3.47	3.89 %	$ 306 M	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	101 M	$ 219.83	-0.92 %	$ 5 B	Danmark
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	4.59 M	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Grifols, S.A. GRFS	7.22 B	$ 7.69	1.39 %	$ 6.83 B	Spain
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
CollPlant Biotechnologies Ltd. CLGN	2.28 M	$ 0.6	-2.83 %	$ 6.87 M	Israel
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Cullinan Management CGEM	277 M	$ 13.01	2.12 %	$ 784 M	USA
Atreca BCEL	12.6 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
Heron Therapeutics HRTX	14.6 M	$ 0.8	2.29 %	$ 133 M	USA
BeiGene, Ltd. BGNE	2 B	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	4.82 M	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	3.35 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	81.7 M	-	-	$ 3.74 B	USA
Bellerophon Therapeutics BLPH	1.93 M	-	-74.18 %	$ 955 K	USA
Incyte Corporation INCY	315 M	$ 91.13	0.38 %	$ 17.8 B	USA
Checkpoint Therapeutics CKPT	2.47 M	-	-	$ 169 M	USA
Clovis Oncology CLVS	579 M	-	-7.23 %	$ 13 M	USA
Inovio Pharmaceuticals INO	107 M	$ 1.6	0.95 %	$ 35.5 M	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Denali Therapeutics DNLI	113 M	$ 21.15	4.86 %	$ 3.48 B	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Inventiva S.A. IVA	13.8 M	$ 6.07	5.02 %	$ 138 M	France
Arbutus Biopharma Corporation ABUS	25.6 M	$ 4.3	1.3 %	$ 714 M	Canada
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Cyclacel Pharmaceuticals CYCC	1.06 M	-	-5.98 %	$ 34.1 M	USA
Decibel Therapeutics DBTX	523 K	-	-	$ 123 M	USA
Deciphera Pharmaceuticals DCPH	15.9 M	-	-	$ 2.18 B	USA
Cardiff Oncology CRDF	451 K	$ 1.8	0.08 %	$ 120 M	USA